COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 2510: Articles 25091-25100  | Next

Universal scaling law for COVID-19 propagation in urban centers
Cardoso, B.-H. F., Goncalves, S.
10.1101/2020.06.22.20137604 — Posted: 2020-06-23
A Macroeconomic SIR Model for COVID-19
Bayraktar, E., Cohen, A., Nellis, A.
10.1101/2020.06.22.20137711 — Posted: 2020-06-23
Spectrum of innate and adaptive immune response to SARS CoV 2 infection across asymptomatic, mild and severe cases; a longitudinal cohort study
Carsetti, R., Zaffina, S., Piano Mortari, E., Terreri, S., Corrente, F., Capponi, C., Palomba, P., Mirabella, M., Cascioli, S., Palange, P., Cuccaro, I., Milito, C., Zumla, A., Maeurer, M., Camisa, V., Vinci, M. R., Santoro, A., Cimini, E., Marchioni, L., Nicastri, E., Palmieri, F., Agrati, C., Ippolito, G., Porzio, O., Concato, C., Onetti Muda, A., Raponi, M., Quintarelli, C., Quinti, I., Locatelli, F.
10.1101/2020.06.22.20137141 — Posted: 2020-06-23 Discussion: Onsite
Derivation and Validation of Clinical Prediction Rule for COVID-19 Mortality in Ontario, Canada
Fisman, D., Greer, A. L., Tuite, A.
10.1101/2020.06.21.20136929 — Posted: 2020-06-23
A Statistical and Dynamical Model for Forecasting COVID-19 Deaths based on a Hybrid Asymmetric Gaussian and SEIR Construct
Syage, J. A.
10.1101/2020.06.21.20136937 — Posted: 2020-06-23
Proteomic blood profiling in mild, severe and critical COVID-19 patients
Patel, H., Ashton, N. J., Dobson, R. J., Anderson, L.-m., Yilmaz, A., Blennow, K., Gisslen, M., Zetterberg, H.
10.1101/2020.06.22.20137216 — Posted: 2020-06-23 Discussion: Onsite | Offsite
Humidity and deposition solution play a critical role in virus inactivation by heat treatment on N95 respirators
Rockey, N., Arts, P. J., Li, L., Harrison, K. R., Langenfeld, K., Fitzsimmons, W. J., Lauring, A. S., Love, N. G., Kaye, K. S., Raskin, L., Roberts, W. W., Hegarty, B., Wigginton, K. R.
10.1101/2020.06.22.20137448 — Posted: 2020-06-23
Obesity during the COVID-19 pandemic: cause of high risk or an effect of lockdown? A population-based electronic health record analysis in 1 958 184 individuals.
Katsoulis, M., Pasea, L., Lai, A., Dobson, R. J., Denaxas, S., Hemingway, H., Banerjee, A.
10.1101/2020.06.22.20137182 — Posted: 2020-06-23
Using Machine Learning to assess Covid-19 risks
Prakash, A., Muthya, S., Arokiaswamy, T. P., Nair, R. S.
10.1101/2020.06.23.20137950 — Posted: 2020-06-23
First results from the UK COVID-19 Serology in Oncology Staff Study (CSOS)
Favara, D. M., Cooke, A., Doffinger, R., Houghton, S., Budriunaite, I., Bossingham, S., McAdam, K., Corrie, P., Ainsworth, N. L.
10.1101/2020.06.22.20136838 — Posted: 2020-06-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).